TBJ Reveals the 2020 Fast 50 Award Winners

BioAgilytix in the News

Outsourcing-Pharma.com logo
November 23, 2017

ATCC Adds Novel In Vitro Model to Expanding Portfolio

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.

Read More

TBJ logo
March 9, 2017

Durham’s BioAgilytix Heading into Expansion Mode

BioAgilytix is beefing up in Durham. The contact research organization is expanding its existing 29,000-square-foot space to roughly 50,000 square feet at 2300 Englert Drive and is planning to hire roughly 60 employees by the end of this year, according to President and CEO Jim Datin.

Read More

GEN Genetic Engineering and Biotechnology News logo
January 1, 2017

Cell-Based Assays Keep Biosimilars on Track

The cell-based assay has become a mainstay of drug development, addressing new concerns raised by the advent of biologics. Whereas small molecule drugs may escape detection by the immune system, larger protein therapeutics, such as monoclonal antibodies, are apt to trigger immunogenic alarms.

Read More